<?xml version="1.0"?>
<Articles JournalTitle="Iranian Journal of Allergy, Asthma and Immunology">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Allergy, Asthma and Immunology</JournalTitle>
      <Issn>1735-1502</Issn>
      <Volume>22</Volume>
      <Issue>6</Issue>
      <PubDate PubStatus="epublish">
        <Year>2023</Year>
        <Month>12</Month>
        <Day>28</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Macrophage Activation Syndrome as a Complication of Chronic Granulomatous Disease: A Case Report</title>
    <FirstPage>600</FirstPage>
    <LastPage>603</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Eduardo</FirstName>
        <LastName>Liquidano-Perez</LastName>
        <affiliation locale="en_US">Immunology Service, National Institute of Pediatrics, Secretariat of Health Mexico, Mexico City, Mexico</affiliation>
      </Author>
      <Author>
        <FirstName>Mariana</FirstName>
        <LastName>Carmona Berr&#xF3;n</LastName>
        <affiliation locale="en_US">Immunology Service, National Institute of Pediatrics, Secretariat of Health Mexico, Mexico City, Mexico</affiliation>
      </Author>
      <Author>
        <FirstName>Rosa Itzel</FirstName>
        <LastName>Carrillo Nieto</LastName>
        <affiliation locale="en_US">Immunology Service, National Institute of Pediatrics, Secretariat of Health Mexico, Mexico City, Mexico</affiliation>
      </Author>
      <Author>
        <FirstName>Celso</FirstName>
        <LastName>Corcuera Delgado</LastName>
        <affiliation locale="en_US">Pathology Department, National Institute of Pediatrics, Secretariat of Health Mexico, Mexico City, Mexico</affiliation>
      </Author>
      <Author>
        <FirstName>Lizbeth</FirstName>
        <LastName>Blancas Galicia</LastName>
        <affiliation locale="en_US">Immunodeficiencies Unit, National Institute of Pediatrics, Secretariat of Health Mexico, Mexico City, Mexico</affiliation>
      </Author>
      <Author>
        <FirstName>Selma</FirstName>
        <LastName>Scheffler Mendoza</LastName>
        <affiliation locale="en_US">Immunology Service, National Institute of Pediatrics, Secretariat of Health Mexico, Mexico City, Mexico</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2022</Year>
        <Month>03</Month>
        <Day>08</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2023</Year>
        <Month>07</Month>
        <Day>26</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Chronic granulomatous disease (CGD) presents with granuloma formation and lethal infections. It is inherited in an autosomal or X-linked recessive pattern. We describe a 10-month-old patient with a fatal secondary HLH as a CGD primary manifestation. We carried out an autopsy and found noncaseating granulomas, an aspergilloma in the lung, and hemophagocytosis. We performed a DHR assay on the patient&#x2019;s mother and grandmother, showing a bimodal pattern conclusive of X-linked CGD. Thus, our definitive diagnosis was CGD complicated by macrophage activation syndrome. CGD is caused by phagocytes&#x2019; inability to control pathogens, resulting in granulomas. Secondary HLH is a severe complication and could be characterized by the proliferation of macrophages and T lymphocytes and the production of proinflammatory cytokines. The early suspicion of this presentation helps establish a specific treatment, and the study of the carriers helps determine the etiology.</abstract>
    <web_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/view/3480</web_url>
    <pdf_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/download/3480/2018</pdf_url>
  </Article>
</Articles>
